Dr Reddys Laboratories (RDY) Total Liabilities (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Total Liabilities of $2.1 billion for Q1 2026, up 16.22% year-over-year from $1.8 billion in Q1 2025, and up 16.22% quarter-over-quarter from $1.8 billion in Q1 2025.
Dr Reddys Laboratories (RDY) Total Liabilities (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Total Liabilities history runs 10 years deep, the most recent figure standing at $2.1 billion for Q1 2026.
- In Q1 2026, Total Liabilities rose 16.22% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (up 16.22% YoY), while the FY2026 annual figure was $2.1 billion, up 16.22% from the prior year.
- Total Liabilities for Q1 2026 stood at $2.1 billion, up from $1.8 billion in the prior quarter.
- The five-year high for Total Liabilities was $2.1 billion in Q1 2026, with the low at $1.1 billion in Q1 2023.
- The 5-year median for Total Liabilities is $1.3 billion (2022), against an average of $1.5 billion.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities dropped 17.95% in 2023, then jumped 42.13% in 2025.
- Dr Reddys Laboratories' Total Liabilities stood at $1.3 billion in 2022, then decreased by 17.95% to $1.1 billion in 2023, then increased by 16.09% to $1.3 billion in 2024, then surged by 42.13% to $1.8 billion in 2025, then gained by 16.22% to $2.1 billion in 2026.
- Business Quant data shows RDY's Total Liabilities at $2.1 billion in Q1 2026, $1.8 billion in Q1 2025, and $1.3 billion in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 2.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 Bn |
| Mar 31, 2025 | 1.83 Bn |
| Mar 31, 2024 | 1.28 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Mar 31, 2022 | 1.35 Bn |
| Mar 31, 2021 | 1.26 Bn |
| Mar 31, 2020 | 1.03 Bn |
| Mar 31, 2019 | 1.23 Bn |
| Mar 31, 2018 | 1.52 Bn |
| Dec 31, 2009 | 691.00 Mn |
| Sep 30, 2009 | 770.00 Mn |
| Jun 30, 2009 | 822.00 Mn |